tiprankstipranks
Trending News
More News >
Blueprint Medicines (BPMC)
NASDAQ:BPMC

Blueprint Medicines (BPMC) Similar Stocks

Compare
566 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Blueprint Medicines
$101.22
$6.57B
-2.92%
11 Buy
4 Hold
0 Sell
Moderate Buy
Alkermes
$31.45
$5.18B
14.96
29.00%
6 Buy
6 Hold
0 Sell
Moderate Buy
Sarepta Therapeutics
$37.94
$3.58B
19.61
-71.00%
18 Buy
5 Hold
0 Sell
Strong Buy
Axsome Therapeutics
$108.30
$5.33B
39.60%
15 Buy
0 Hold
0 Sell
Strong Buy
BridgeBio Pharma
$33.69
$6.43B
14.13%
14 Buy
1 Hold
0 Sell
Strong Buy
Revolution Medicines
$39.93
$7.37B
-0.25%
12 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BPMC
Blueprint Medicines
101.22
-3.04
-2.92%
ALKS
Alkermes
31.45
7.07
29.00%
SRPT
Sarepta Therapeutics
37.94
-92.89
-71.00%
AXSM
Axsome Therapeutics
108.30
30.72
39.60%
BBIO
BridgeBio Pharma
33.69
4.17
14.13%
RVMD
Revolution Medicines
39.93
-0.10
-0.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis